efficacy of glp 1 receptor agonists The role GLP-1 as weight loss agents in patients with and without type 2 diabetes Mechanistic Pathways and Comparative Efficacy
Description
Cancer statistics, 2025
Glucagon-like peptide-1 and its class B G protein-coupled receptors: A long march to therapeutic successes
In the early stages of HF, compensatory mechanisms reduce the impact of the cardiac dysfunction
Food & Drug Administration, FDA Approves New Medication for Chronic Weight Management (2023)
DPP-4 inhibitors appear to have additive A1C-lowering effects in combination with other oral agents used to treat diabetes
[DOI] [PMC free article] [PubMed] [Google Scholar] 771.Carraro-Lacroix L.R., Malnic G., Girardi A.C
